Michael D. West - 11 Mar 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role: Chief Executive Officer
Signature: /s/Michael D. West
Issuer symbol: SER
Transactions as of: 11 Mar 2023
Net transactions value: -$625
Form type: 4
Filing time: 14 Mar 2023, 21:32:33 UTC
Previous filing: 13 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AGE	Common Stock, $0.0001 par value	Options Exercise	$0	+3,125	+7.8%	$0.000000	43,042	11 Mar 2023	Direct	F1
transaction	AGE	Common Stock, $0.0001 par value	Tax liability	$625	-1,060	-2.5%	$0.5900	41,982	11 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AGE	Restricted Stock Units	Options Exercise	$0	-3,125	-100%	$0.000000^*	0	11 Mar 2023	Common Stock	3,125	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Excludes shares owned by former spouse of which Dr. West disclaims beneficial ownership.
F2	Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F3	Restricted Stock Units vested on March 11, 2023.